FULC- Fulcrum Therapeutics, Inc.

FULC sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Ra Capital Management, L.P.	8.85M	$118.00M	-
10%	Tang Kevin	7.08M	$24.92M	-
Other	Sapir Alex	650.0K	-	-
CFO	Musso Alan A	170.0K	-	-
Other	Oltmans Curtis Gale	170.0K	-	-

Buys and sells only

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 8, 2024	Tourangeau Greg49	Vice President, Finance	Sell	4,884	$11.72	$57,218.50	-29.3%	-24.5%	-71.7%
Mar 4, 2024	Sapir Alex	See Remarks	Buy	43,360	$11.35	$492,027.60	New	-27.8%	-71.1%
May 10, 2023	Tourangeau Greg49	Principal Accounting Officer	Sell	210	$3.31	$695.10	-1.3%	+23.2%	+129.4%
Jan 20, 2023	Ra Capital Management, L.P.52	10% Owner	Buy	1,923,076	$13.00	$24,999,988.00	+19.9%	-80.4%	-45.2%
Jan 13, 2023	Gould Robert J85	Interim President &CEO	Sell	6,766	$15.00	$101,490.00	-1.3%	-81.7%	-48.2%
Jan 4, 2023	Ra Capital Management, L.P.52	10% Owner	Buy	180,703	$7.28	$1,314,805.84	+1.9%	-68.4%	-10.5%
Dec 27, 2022	Ra Capital Management, L.P.52	10% Owner	Buy	4,089	$5.99	$24,509.87	-	-48.3%	+11.8%
Dec 19, 2022	Ra Capital Management, L.P.52	10% Owner	Buy	98,787	$5.90	$582,813.66	+1.1%	-42.9%	-2.0%
Dec 16, 2022	Ra Capital Management, L.P.52	10% Owner	Buy	2,403,049	$5.44	$13,073,873.91	+34.3%	-31.2%	+0.7%
Jun 7, 2022	Gould Robert J85	Director	Sale+OE	71,435	$8.09	$577,894.86	-12.4%	-7.3%	-60.9%